Stock Market Reviews

Read and share opinions on RGNX (REGENXBIO Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Earnings Update: REGENXBIO Inc. (NASDAQ:RGNX) Just Reported And Analysts Are Boosting Their Estimates
  Nov 9, 2025
• Regenxbio Inc (RGNX) Q3 2025 Earnings Call Highlights: Strong Financial Position and Strategic ...
  Nov 6, 2025
• Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates
  Nov 6, 2025
• Regenxbio: Q3 Earnings Snapshot
  Nov 6, 2025
• REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights
  Nov 6, 2025
• REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program
  Oct 30, 2025
• REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights
  Oct 29, 2025
• REGENXBIO to Participate in Upcoming Investor Conferences
  Oct 15, 2025
• REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting
  Oct 9, 2025
• REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
  Oct 6, 2025
• REGENXBIO Announces Presentation at the World Muscle Society
  Sep 29, 2025
• Regenxbio Unveils 12-Month Data For Gene Therapy Soon After FDA Delays Review Date
  Sep 5, 2025
• REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II
  Sep 5, 2025
• REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II
  Aug 18, 2025
• Are Options Traders Betting on a Big Move in Regenxbio Stock?
  Aug 12, 2025
• These Analysts Just Made An Incredible Downgrade To Their REGENXBIO Inc. (NASDAQ:RGNX) EPS Forecasts
  Aug 9, 2025
• Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates
  Aug 7, 2025
• Regenxbio: Q2 Earnings Snapshot
  Aug 7, 2025
• REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights
  Aug 7, 2025